Obagi Nu-Derm® Clear Fx 57g
Obagi Nu-Derm Clear Fx skin-brightening cream corrects dark spots and sun spots for clear, smooth and more healthy-looking skin when used as part of Obagi Nu-Derm Fx System
Did you know? UV light, which radiates from the sun, can cause damage your skin and even premature ageing of the complexion, often leading to hyperpigmentation. Obagi Nu-Derm Clear Fx works to fade these dark spots and give you a brighter, more even skin tone.
This Arbutin-based, skin-brightening cream works in a gentle formula to minimise imperfections and pigmentation caused by spots, outbreaks and sun damage. Extracted from Bearberry plants, Arbutin (7%) used in Obagi Nu-Derm Clear Fx prevents the production of tyrosinase - the enzyme in the skin responsible for melanin production that leads to dark spots, also known as sun spots.
Additional antioxidants including Lactic Acid help enhance the appearance of even skin tone while protecting the skin from free radicals. Obagi Clear Fx #3 is the third step in your morning skin care regime when using Obagi Nu-Derm Fx.
*Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
Obagi Nu-Derm Clear Fx skin-brightening cream corrects dark spots and sun spots for clear, smooth and more healthy-looking skin when used as part of Obagi Nu-Derm Fx System
Did you know? UV light, which radiates from the sun, can cause damage your skin and even premature ageing of the complexion, often leading to hyperpigmentation. Obagi Nu-Derm Clear Fx works to fade these dark spots and give you a brighter, more even skin tone.
This Arbutin-based, skin-brightening cream works in a gentle formula to minimise imperfections and pigmentation caused by spots, outbreaks and sun damage. Extracted from Bearberry plants, Arbutin (7%) used in Obagi Nu-Derm Clear Fx prevents the production of tyrosinase - the enzyme in the skin responsible for melanin production that leads to dark spots, also known as sun spots.
Additional antioxidants including Lactic Acid help enhance the appearance of even skin tone while protecting the skin from free radicals. Obagi Clear Fx #3 is the third step in your morning skin care regime when using Obagi Nu-Derm Fx.
*Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
Obagi Nu-Derm Clear Fx skin-brightening cream corrects dark spots and sun spots for clear, smooth and more healthy-looking skin when used as part of Obagi Nu-Derm Fx System
Did you know? UV light, which radiates from the sun, can cause damage your skin and even premature ageing of the complexion, often leading to hyperpigmentation. Obagi Nu-Derm Clear Fx works to fade these dark spots and give you a brighter, more even skin tone.
This Arbutin-based, skin-brightening cream works in a gentle formula to minimise imperfections and pigmentation caused by spots, outbreaks and sun damage. Extracted from Bearberry plants, Arbutin (7%) used in Obagi Nu-Derm Clear Fx prevents the production of tyrosinase - the enzyme in the skin responsible for melanin production that leads to dark spots, also known as sun spots.
Additional antioxidants including Lactic Acid help enhance the appearance of even skin tone while protecting the skin from free radicals. Obagi Clear Fx #3 is the third step in your morning skin care regime when using Obagi Nu-Derm Fx.
*Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.